Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SF3B4P1 (splicing factor 3b, subunit 4 pseudogene 1) is a human pseudogene corresponding to the functional SF3B4 gene. Unlike its functional counterpart, SF3B4P1 does not encode a protein and has no known biological function or clinical relevance. Pseudogenes are typically non-functional genomic DNA sequences similar to known genes but generally not expressed as a functional protein. There is currently no evidence that SF3B4P1 plays a role in disease, serves as a therapeutic target, or has any known interactions with drugs. SF3B4P1 is annotated and classified specifically as a pseudogene and not as a protein-coding gene. The functionally relevant gene/protein is SF3B4 (splicing factor 3B subunit 4), which is involved in mRNA splicing and associated with disorders such as Nager syndrome and Rodriguez acrofacial dysostosis; however, this function and disease relevance do not extend to the pseudogene SF3B4P1. Pseudogenes, including SF3B4P1, do not produce functional protein products and are not recognized as drug targets, biomarkers, or molecular entities for therapeutic intervention. There is no evidence in human gene or protein databases (GeneCards, Merck, UniProt) indicating that SF3B4P1 is involved in any biological process, pathway, or disease, nor is it a receptor, enzyme, or other druggable entity. The functional gene, SF3B4, should not be confused with SF3B4P1. If a biologically or clinically relevant target is desired, the correct entity would be "Splicing factor 3b subunit 4 (SF3B4)," not SF3B4P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Splicing factor 3b, subunit 4 pseudogene 1 (SF3B4P1).